1. Academic Validation
  2. Integrated network pharmacology and therapeutic verification of Dendrobium officinale flower on primary dysmenorrhea via inhibition of the TLR4/NF-κB/COX-2 pathway

Integrated network pharmacology and therapeutic verification of Dendrobium officinale flower on primary dysmenorrhea via inhibition of the TLR4/NF-κB/COX-2 pathway

  • Fitoterapia. 2025 Oct 6:187:106924. doi: 10.1016/j.fitote.2025.106924.
Manman Li 1 Pei Sheng 2 Weiqing Shi 3 Weiguang Li 4 Luqian Li 5 Xue Wang 5 Haixia Wu 5 Yuxin Wang 1 Xiaofei An 6 Lei Wang 7 Ming Yan 8
Affiliations

Affiliations

  • 1 School of Traditional Chinese Pharmacy, China Pharmaceutical University, Nanjing 211198, Jiangsu Province, China.
  • 2 Department of Endocrinology, Affiliated Hospital of Nanjing University of Chinese Medicine, Nanjing 210009, Jiangsu Province, China.
  • 3 Jiangsu Provincial Center for Disease Control and Prevention, Nanjing 210009, Jiangsu Province, China. Electronic address: shiwq@jscdc.cn.
  • 4 School of Life Science and Technology, China Pharmaceutical University, Nanjing 211198, Jiangsu Province, China.
  • 5 New Drug Screening and Pharmacodynamics Evaluation Center, State Key Laboratory of Natural Medicines, China Pharmaceutical University, Nanjing 210009, Jiangsu Province, China.
  • 6 Department of Endocrinology, Affiliated Hospital of Nanjing University of Chinese Medicine, Nanjing 210009, Jiangsu Province, China. Electronic address: anxiaofei2000@163.com.
  • 7 School of Traditional Chinese Pharmacy, China Pharmaceutical University, Nanjing 211198, Jiangsu Province, China. Electronic address: wanglei@cpu.edu.cn.
  • 8 New Drug Screening and Pharmacodynamics Evaluation Center, State Key Laboratory of Natural Medicines, China Pharmaceutical University, Nanjing 210009, Jiangsu Province, China. Electronic address: brookming@cpu.edu.cn.
Abstract

Dendrobium officinale flowers (DOF) offer a wide range of therapeutic benefits due to their rich content of bioactive compounds. Traditionally used in Chinese medicine, these flowers are valued for their health benefits, including anti-inflammatory and antioxidant properties, which may contribute to their therapeutic effects. The anti-inflammatory and antioxidant extract of DOF exhibited anti-primary dysmenorrhea (PD) activity in oxytocin-induced mice. This study aimed to unravel the underlying mechanisms of DOF-EA in treating PD using an integrative approach that combines network pharmacology and experimental verification. The active fraction, DOF-EA, was identified through anti-inflammatory and antioxidant activity assays. The phytochemical profile of DOF-EA was characterized by HPLC analysis. The therapeutic mechanisms of DOF-EA in treating PD were predicted using network pharmacology and molecular docking analyses. Moreover, the therapeutic effects of DOF-EA were confirmed using oxytocin-induced mice and uterine strip models. Enzyme activity assays and immunoblotting methods were employed for target validation. DOF-EA inhibited COX-2 with an IC50 of 0.44 μg/mL, scavenged DPPH radicals with an IC50 of 9.88 μg/mL, and suppressed NO production in RAW 264.7 cells with an IC50 of 8.08 μg/mL. Additionally, DOF-EA reduced the writhing response and decreased TNF-α and PGF levels in PD mice. It also inhibited contraction activity in uterine strips by blocking calcium channels. Furthermore, DOF-EA downregulated the expression of TLR4, NF-κB, COX-2, and p-IκBα, while upregulating the expression of HO-1 and Nrf2 in the uterine tissue of PD mice. In conclusion, DOF-EA exerts therapeutic effects against PD by inhibiting TLR4/NF-κB/COX-2 and promoting the Nrf2/HO-1 pathway.

Keywords

COX-2; Dendrobium officinale flowers; NF-κB; Network pharmacology; Primary dysmenorrhea; TLR4.

Figures
Products